Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioNTech SE (BNTX – Research Report) and ...

Join us for a quick overview of BioNTech SE, a Biotechnology company whose shares moved 0.3% today. Here are some facts about ...

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on BioNTech SE (BNTX – Research Report). The ...

BioNTech ADR saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 66 to 79. Please watch ...